JP2015504432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504432A5 JP2015504432A5 JP2014542646A JP2014542646A JP2015504432A5 JP 2015504432 A5 JP2015504432 A5 JP 2015504432A5 JP 2014542646 A JP2014542646 A JP 2014542646A JP 2014542646 A JP2014542646 A JP 2014542646A JP 2015504432 A5 JP2015504432 A5 JP 2015504432A5
- Authority
- JP
- Japan
- Prior art keywords
- relates
- trimethoxyphenyl
- hydrazide
- hydrazones
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1107312-8A BRPI1107312B1 (pt) | 2011-11-25 | 2011-11-25 | Composto de acil-hidrazona |
| BRPI1107312-8 | 2011-11-25 | ||
| PCT/BR2012/000480 WO2013075199A1 (pt) | 2011-11-25 | 2012-11-26 | "compostos acil-hidrazonas e oxadiazóis, composições farmacêuticas compreendendo os mesmos e seus usos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015504432A JP2015504432A (ja) | 2015-02-12 |
| JP2015504432A5 true JP2015504432A5 (enExample) | 2016-01-21 |
Family
ID=48468927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014542646A Pending JP2015504432A (ja) | 2011-11-25 | 2012-11-26 | アシル−ヒドラゾンおよびオキサジアゾール化合物、これらを含有する医薬組成物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150191445A1 (enExample) |
| EP (1) | EP2784061B1 (enExample) |
| JP (1) | JP2015504432A (enExample) |
| KR (1) | KR102189562B1 (enExample) |
| CN (1) | CN104159887A (enExample) |
| BR (2) | BRPI1107312B1 (enExample) |
| CA (1) | CA2869807C (enExample) |
| RU (1) | RU2664327C2 (enExample) |
| WO (1) | WO2013075199A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101719541B1 (ko) | 2015-08-13 | 2017-03-24 | 연세대학교 산학협력단 | 항암용 약학 조성물 및 ano1 활성억제제 |
| KR20170141542A (ko) * | 2016-06-15 | 2017-12-26 | 국립암센터 | 위암을 예방 및 치료하는 rhoa 억제제의 약학적 조성물 |
| CN110498809B (zh) * | 2018-05-17 | 2022-04-05 | 香港科技大学深圳研究院 | 基于酰腙配体类的有机硼化合物及其制备方法和应用 |
| KR102131331B1 (ko) | 2018-09-19 | 2020-07-07 | 연세대학교 산학협력단 | 항암용 신규 약학 조성물 및 ano1 활성억제제 |
| CN113336729B (zh) * | 2021-05-31 | 2022-05-27 | 四川大学华西医院 | 硝呋齐特类衍生物及其制备方法和用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60105621A (ja) * | 1983-11-14 | 1985-06-11 | Agency Of Ind Science & Technol | 細胞の分化誘導作用を有する生理活性物質およびその製法 |
| IL94389A0 (en) * | 1989-06-01 | 1991-03-10 | Health Research Inc | Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and method of using same for diagnosis and treatment |
| US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| US6197806B1 (en) * | 1995-12-20 | 2001-03-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Eliminating agent for activated oxygen and free radicals |
| CA2400996A1 (en) | 2002-09-03 | 2004-03-03 | Lisa Mckerracher | 1,4-substituted cyclohexane derivatives |
| KR101155883B1 (ko) | 2003-12-23 | 2012-06-20 | 아제닉스 유에스에이 인코포레이티드 | 사이클린 의존적 키나제 저해제, 그 조성물 및 그의 용도 |
| DE102004010207A1 (de) | 2004-03-02 | 2005-09-15 | Aventis Pharma S.A. | Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate |
| WO2005097763A2 (en) * | 2004-04-01 | 2005-10-20 | Aventis Pharmaceuticals Inc. | 1,3,4-oxadiazol-2-ones as ppar delta |
| AR052559A1 (es) | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
| WO2006101937A1 (en) | 2005-03-18 | 2006-09-28 | Janssen Pharmaceutica N.V. | Acylhydrazones as kinase modulators |
| CN1824657A (zh) * | 2006-04-05 | 2006-08-30 | 贵州大学 | 3－取代－2－芳基取代－5－(3,4,5－三烷氧基苯基)－1,3,4－噁二唑衍生物及制备方法和用途 |
| US20110189306A1 (en) * | 2010-01-13 | 2011-08-04 | Norbert Kartner | COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES |
-
2011
- 2011-11-25 BR BRPI1107312-8A patent/BRPI1107312B1/pt not_active IP Right Cessation
-
2012
- 2012-11-26 EP EP12851308.2A patent/EP2784061B1/en active Active
- 2012-11-26 WO PCT/BR2012/000480 patent/WO2013075199A1/pt not_active Ceased
- 2012-11-26 JP JP2014542646A patent/JP2015504432A/ja active Pending
- 2012-11-26 RU RU2014125519A patent/RU2664327C2/ru active
- 2012-11-26 KR KR1020147017498A patent/KR102189562B1/ko active Active
- 2012-11-26 CA CA2869807A patent/CA2869807C/en active Active
- 2012-11-26 US US14/360,279 patent/US20150191445A1/en not_active Abandoned
- 2012-11-26 BR BR112014012582A patent/BR112014012582A2/pt not_active IP Right Cessation
- 2012-11-26 CN CN201280063518.9A patent/CN104159887A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT4303583T (lt) | Csf1r inhibitoriai, skirti panaudoti gydant tenosinovinius gigantinių ląstelių navikus | |
| HK1217215A1 (zh) | 用於改变细胞表型的信号传感器多核苷酸 | |
| CN110198943A (zh) | 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物 | |
| WO2014191359A9 (en) | Aptamers and use of the aptamers in the diagnosis and treatment of cancer | |
| DE112012006327A5 (de) | Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) | |
| CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
| JP2014530840A5 (enExample) | ||
| WO2015067715A3 (en) | Gip-glp-1 dual agonist compounds and methods | |
| DK3124043T3 (da) | Hidtil ukendt immunterapi mod flere forskellige tumorer, herunder nerve- og hjernetumorer | |
| MX2014011134A (es) | Compuestos de carbamato y preparacion y uso de los mismos. | |
| CO6791606A2 (es) | Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas | |
| DK3195873T3 (da) | Hidtil ukendt immunterapi mod flere forskellige tumortyper, herunder mave-tarm-cancer og mavecancer | |
| CN109843873A (zh) | 炔代杂环化合物、其制备方法及其在医药学上的应用 | |
| CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
| HK1217650A1 (zh) | 用於治疗剧痛的组合物及方法 | |
| BRPI0909818A2 (pt) | métodos, formas de dosagem e conjunto para administrar ziprasidona sem alimentos | |
| JP2015502958A5 (enExample) | ||
| JP2015504432A5 (enExample) | ||
| JP2014519480A5 (enExample) | ||
| WO2011159693A3 (en) | Oral treatment of digital ischemic lesions | |
| CL2011002965A1 (es) | Compuestos derivados de piperidinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso de dichos compuestos para el tratamiento y/o profilaxis de trastornos cardiovasculares, tromboembolicos y/o tumores. | |
| JP2013231052A5 (enExample) | ||
| JP2016503275A5 (enExample) | ||
| JP2014510253A5 (enExample) | ||
| JP2013100268A5 (enExample) |